The DOI matches its Crossref record; 515 of the 515 references it cites were found in a registry or an index.
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Abstract
The neurohypophysial hormone arginine vasopressin (AVP) is essential for a wide range of physiological functions, including water reabsorption, cardiovascular homeostasis, hormone secretion, and social behavior. These and other actions of AVP are mediated by at least three distinct receptor subtypes: V1a, V1b, and V2. Although the antidiuretic action of AVP and V2 receptor in renal distal tubules and collecting ducts is relatively well understood, recent years have seen an increasing understanding of the physiological roles of V1a and V1b receptors. The V1a receptor is originally found in the vascular smooth muscle and the V1b receptor in the anterior pituitary. Deletion of V1a or V1b receptor genes in mice revealed that the contributions of these receptors extend far beyond cardiovascular or hormone-secreting functions. Together with extensively developed pharmacological tools, genetically altered rodent models have advanced the understanding of a variety of AVP systems. Our report reviews the findings in this important field by covering a wide range of research, from the molecular physiology of V1a and V1b receptors to studies on whole animals, including gene knockout/knockdown studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–515 of 515
Bhuiyan, A. K. M., Bartlett, K., Sherratt, H. S. A., & Agius, L. (1988) · Biochemical Journal · doi:10.1042/bj2530337 · Cited by 38
Chapter 1.4 Vasopressin binding sites in the central nervous system: Distribution and regulation
Tribollet, E., Arsenijévic, Y., & Barberis, C. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61561-7 · Cited by 38
Nicou, A., Serrière, V., Prigent, S., Boucherie, S., Combettes, L., Guillon, G., Alonso, G., & Tordjmann, T. (2003) · The FASEB Journal · doi:10.1096/fj.03-0082fje · Cited by 38
Bachner‐Melman, R., Zohar, A. H., Elizur, Y., Nemanov, L., Gritsenko, I., Konis, D., & Ebstein, R. P. (2004) · International Journal of Eating Disorders · doi:10.1002/eat.20049 · Cited by 38
Mazzocchi, G., Malendowicz, L. K., Rebuffat, P., Tortorella, C., & Nussdorfer, G. G. (1997) · Peptides · doi:10.1016/s0196-9781(96)00294-x · Cited by 37
Yanai, N., Satoh, T., Kyo, S., Abe, K., Suzuki, M., & Masuo, M. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01803.x · Cited by 37
Engin, E., & Treit, D. (2008) · Neuropeptides · doi:10.1016/j.npep.2008.04.004 · Cited by 37
Orcel, H., Albizu, L., Perkovska, S., Durroux, T., Mendre, C., Ansanay, H., Mouillac, B., & Rabié, A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049031 · Cited by 36
Fujiwara, Y., Hiroyama, M., Sanbe, A., Yamauchi, J., Tsujimoto, G., & Tanoue, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.06864 · Cited by 36
Self-citationAltered lipid metabolism in vasopressin V receptor-deficient mice
Hiroyama, M., Fujiwara, Y., Nakamura, K., Aoyagi, T., Mizutani, R., Sanbe, A., Tasaki, R., & Tanoue, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.11.043 · Cited by 36
Self-citationEnhanced effect of neuropeptide Y on food intake caused by blockade of the V1A vasopressin receptor
Aoyagi, T., Kusakawa, S., Sanbe, A., Hiroyama, M., Fujiwara, Y., Yamauchi, J., & Tanoue, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.017 · Cited by 35
Self-citationGuillon, G., Derick, S., Peña, A., Cheng, L., Stoev, S., Seyer, R., Morgat, J. L., Barberis, C., Gal, C. S., Wagnon, J., et al. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.0953-8194.2004.01163.x · Cited by 35
Thibonnier, M., Coles, P., Conarty, D. M., Plesnicher, C. L., & Shoham, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39056-1 · Cited by 35
Andrés, M., Trueba, M., & Guillon, G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704634 · Cited by 34
Tahara, A., Tsukada, J., Tomura, Y., Yatsu, T., & Shibasaki, M. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.01.003 · Cited by 34
Zelena, D., Langnaese, K., Domokos, Á., Pintér, O., Landgraf, R., Makara, G. B., & Engelmann, M. (2009) · Endocrinology · doi:10.1210/en.2008-1007 · Cited by 34
Effects of Arginine Vasopressin on Growth of Rat Cardiac Fibroblasts: Role of V1 Receptor
Yang, X., Zhao, L., Zheng, Q., & Li, X. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200307000-00020 · Cited by 34
O’Carroll, A., Howell, G. M., Roberts, E., & Lolait, S. J. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0645 · Cited by 33
Náray‐Fejes‐Tóth, A., Rusvai, E., & Fejes‐Tóth, G. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.1.f76 · Cited by 33
Hawtin, S. R., Wesley, V. J., Parslow, R. A., Patel, S., & Wheatley, M. (2000) · Biochemistry · doi:10.1021/bi0013400 · Cited by 32
Roper, J. A., Craighead, M. W., O'Carroll, A.-M., & Lolait, S. J. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02070.x · Cited by 32
Novel Agents for the Treatment of Hyponatremia
Ferguson-Myrthil, N. (2010) · Cardiology in Review · doi:10.1097/crd.0b013e3181f5b3b7 · Cited by 32
Ramos, A. T., Troncone, L. R. P., & Tufik, S. (2006) · Neuroendocrinology · doi:10.1159/000097587 · Cited by 32
Breuer, M. E., van Gaalen, M. M., Wernet, W., Claessens, S. E. F., Oosting, R. S., Behl, B., Korte, S. M., Schoemaker, H., Gross, G., Olivier, B., et al. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0336-1 · Cited by 32
Pharmacology of Oxytocin and Vasopressin Receptors in the Central and Peripheral Nervous Systema
Barberis, C., Audigier, S., Durroux, T., Elands, J., Schmidt, A., & Jard, S. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb34344.x · Cited by 32
Hensen, J., Hader, O., Bähr, V., & Oelkers, W. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-4-668 · Cited by 32
Kjær, A., Knigge, U., Bach, F. W., & Warberg, J. (2008) · Neuroendocrinology · doi:10.1159/000126468 · Cited by 31
Phosphorylation and Recycling Kinetics of g Protein-Coupled Receptors
Innamorati, G., Hamid, M., & Birnbaumer, M. (1999) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899909036654 · Cited by 31
Adrenalectomy enhances the insulin sensitivity of muscle protein synthesis
Long, W., Barrett, E. J., Wei, L., & Liu, Z. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00028.2002 · Cited by 31
Multiple Sites of Vasopressin Synthesis in the Injured Brain
Szmydynger‐Chodobska, J., Zink, B. J., & Chodobski, A. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.188 · Cited by 31
Urani, A., Philbert, J., Cohen, C., & Griebel, G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.019 · Cited by 31
Spiga, F., Harrison, L. R., MacSweeney, C. P., Thomson, F. J., Craighead, M., & Lightman, S. L. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0425 · Cited by 30
Evidence that atypical vasopressin V2 receptor in inner medulla of kidney is V1B receptor
Saito, M., Tahara, A., Sugimoto, T., Abe, K., & Furuichi, K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00465-9 · Cited by 30
Gal, C. S., Bourrié, B., Raufaste, D., Carayon, P., Garcia, C., Maffrand, J., Fur, G. L., & Casellas, P. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90125-2 · Cited by 30
Alexander, S. L., Roud, H., & IRVINE, C. H. G. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1530401 · Cited by 30
Roberts, E., Pope, G. R., Newson, M. J. F., Lolait, S. J., & O’Carroll, A. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02074.x · Cited by 29
Role of l -glutamate in systemic AVP-induced hypothermia
Paro, F. M., Almeida, M. C., Cárnio, E. C., & Branco, L. G. S. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00291.2002 · Cited by 29
Acylcarnitine Metabolism during Fasting and after Refeeding
Yamaguti, K., Kuratsune, H., Watanabe, Y., Takahashi, M., Nakamoto, I., Machii, T., Jacobsson, G., Onoe, H., Matsumura, K., Valind, S., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1244 · Cited by 29
Richardson, S. B., Eyler, N., Twente, S., Monaco, M. E., ALTSZULER, N., & GIBSON, M. (1990) · Endocrinology · doi:10.1210/endo-126-2-1047 · Cited by 29
Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor
Itoh, S., Yamada, S., Mori, T., Miwa, T., Tottori, K., Uwahodo, Y., Yamamura, Y., Fukuda, M., Yamamoto, K., Tanoue, A., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00005.2006 · Cited by 29
Self-citationAdvances in Vasopressin and Oxytocin — From Genes to Behaviour to Disease
(2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00453-6 · Cited by 28
Effects of Acute Metabolic Stress on the Peripheral Vasopressinergic System in Schizophrenia
Elman, I., Lukas, S. E., Shoaf, S. E., Rott, D., Adler, C. M., & Breier, A. F. (2003) · Journal of Psychopharmacology · doi:10.1177/02698811030173014 · Cited by 28
Enhanced glucose tolerance in the Brattleboro rat
Nakamura, K., Yamashita, T., Fujiki, H., Aoyagi, T., Yamauchi, J., Mori, T., & Tanoue, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.126 · Cited by 28
Self-citationAlcohol preference in mice lacking the Avpr1a vasopressin receptor
Sanbe, A., Takagi, N., Fujiwara, Y., Yamauchi, J., Endo, T., Mizutani, R., Takeo, S., Tsujimoto, G., & Tanoue, A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00708.2007 · Cited by 27
Self-citationÅkerlund, M., Melin, P., & Maggi, M. (1995) · PubMed · Cited by 27
Characterization of a novel and selective V1B receptor antagonist
Craighead, M. W., Milne, R. J., Campbell-Wan, L., WATSON, L., Presland, J. P., THOMSON, F. J., Marston, H. M., & MacSweeney, C. P. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00440-8 · Cited by 26
EFFECTS OF LYSINE‐VASOPRESSIN AND OXYTOCIN ON CENTRAL CARDIOVASCULAR CONTROL
Tran, L. D., Montastruc, J., & Montastruc, P. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09270.x · Cited by 26
Downregulation of vasopressin V2receptor promoter activity via V1areceptor pathway
Izumi, Y., Nakayama, Y., Mori, T., Miyazaki, H., Inoue, H., Kohda, Y., Inoue, T., Nonoguchi, H., & Tomita, K. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00358.2006 · Cited by 26
Self-citationNakamura, K., Fujiwara, Y., Mizutani, R., Sanbe, A., Miyauchi, N., Hiroyama, M., Yamauchi, J., Yamashita, T., Nakamura, S., Mori, T., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1528 · Cited by 25
Self-citationVasopressin accelerates protein synthesis in neonatal rat cardiomyocytes
Xu, Y., Hopfner, R. L., McNeill, J. R., & Gopalakrishnan, V. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006961330375 · Cited by 25
Integrative Mechanism of Neuroendocrine System
伊藤, 眞. (1968) · Cited by 25
Identification of agonist binding sites of vasopressin and oxytocin receptors.
Mouillac, B., Chini, B., Balestre, M., Jard, S., Barberis, C., Manning, M., Tribollet, E., Trumpp-Kallmeyer, S., Hoflack, J., & Elands, J. (1995) · PubMed · Cited by 25
Bossmar, T., Brouard, R., Döberl, A., & Åkerlund, M. (1997) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb11500.x · Cited by 25
Yibchok‐anun, S., & Hsu, W. H. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00463-9 · Cited by 25
Hawtin, S. R., Wesley, V. J., Parslow, R. A., Simms, J., Miles, A., McEwan, K., & Wheatley, M. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.3.0795 · Cited by 25
Vasopressin V1A receptor enhances baroreflex via the central component of the reflex arc
Oikawa, R., Nasa, Y., Ishii, R., Kuwaki, T., Tanoue, A., Tsujimoto, G., & Takeo, S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.063 · Cited by 25
Self-citationCorbani, M., Trueba, M., Stoev, S. B., Murat, B., Mion, J., Boulay, V., Guillon, G., & Manning, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1016208 · Cited by 25
Vasopressin pressor receptor-mediated activation of HPA axis by acute ethanol stress in rats
László, F. A., Varga, C., Pavo, I. J., Gardi, J., Vecsernyés, M., Gálfi, M., Morschl, É., László, F. A., & Makara, G. B. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.2.r458 · Cited by 25
Hawtin, S. R., Wesley, V. J., Simms, J., Argent, C. C. H., Latif, K., & Wheatley, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0148 · Cited by 24
Geenen, Kecha, & Martens (1998) · Journal of neuroendocrinology · doi:10.1046/j.1365-2826.1998.00269.x · Cited by 24
Ferrier, L., Gal, C. S., Schulte, A. M., Vasina, V. I., Gaultier, E., Schroedel, S., Ursino, M. G., Chaumaz, G., Pascal, M., Ponti, F. D., et al. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00022.2010 · Cited by 24
Derick, S., Peña, A., Durroux, T., Wagnon, J., Gal, C. S., Hibert, M., Rognan, D., & Guillon, G. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0124 · Cited by 24
Critical appraisal and clinical utility of atosiban in the management of preterm labor
Sanu, O., & Lamont (2010) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s9378 · Cited by 24
Birumachi, J., Hiroyama, M., Fujiwara, Y., Aoyagi, T., Sanbe, A., & Tanoue, A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.022 · Cited by 23
Self-citationMontero, S., Mendoza, H., Valles, V., Lemus, M., Álvarez-Buylla, R., & de Álvarez-Buylla, E. R. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01414.2005 · Cited by 23
Role of Urinary Arginine Vasopressin in the Sodium Excretion in Patients With Chronic Renal Failure
Nonoguchi, H., Takayama, M., Owada, A., Ujiie, K., Yamada, T., Nakashima, O., Sakuma, Y., Koike, J., Terada, Y., Marumo, F., et al. (1996) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199611000-00001 · Cited by 23
Self-citationSteinwall, M., Bossmar, T., Gaud, C., & Åkerlund, M. (2003) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2004.00320.x · Cited by 23
All Three Vasopressin Receptor Sub-Types are Expressed by Small-Cell Carcinoma
North, W. G., Fay, M. J., & Du, J. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_42 · Cited by 23
Discontinued psychiatric drugs in 2008
Kirchhoff, V., Nguyen, H. T., Soczynska, J. K., Woldeyohannes, H. O., & McIntyre, R. S. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903184591 · Cited by 22
Yarkov, A., Montero, S., Lemus, M., de Álvarez-Buylla, E. R., & Álvarez-Buylla, R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02404-0 · Cited by 22
Body water balance and body temperature in vasopressin V1b receptor knockout mice
Daikoku, R., Kunitake, T., Kato, K., Tanoue, A., Tsujimoto, G., & Kannan, H. (2007) · Autonomic Neuroscience · doi:10.1016/j.autneu.2007.04.002 · Cited by 22
Self-citationEffects of the Neurohypophysial Hormones on Insulin Secretion
KANETO, A., Kosaka, K., & Nakao, K. (1967) · Endocrinology · doi:10.1210/endo-81-4-783 · Cited by 22
Hiroyama, M., Aoyagi, T., Fujiwara, Y., Oshikawa, S., Sanbe, A., Endo, F., & Tanoue, A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.129569 · Cited by 21
Self-citationSharma, A., Masri, J., Jo, O. D., Bernath, A., Martin, J., Funk, A., & Gera, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608874200 · Cited by 21
Thibonnier, M., Plesnicher, C. L., Berrada, K., & Berti‐Mattera, L. N. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.1.e81 · Cited by 21
Terlipressin and hepatorenal syndrome: What is important for nephrologists and hepatologists
Magan, A. A. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i41.5139 · Cited by 21
Nishihashi, T., Trandafir, C., Wang, A., et al. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.051 · Cited by 20
Gewirtz, D. A., Randolph, J. K., & Goldman, D. I. (1984) · Hepatology · doi:10.1002/hep.1840040207 · Cited by 20
Domokos, Á., Mergl, Z., Barna, I., Makara, G. B., & Zelena, D. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0356 · Cited by 19
Brouard, R., Laporte, V., Gal, C. S., Pignol, R., Jang, H., Donat, F., Lockwood, G. F., Fournié‐Lloret, D., & Dreux, F. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_59 · Cited by 19
Lu, M., Soltoff, S. P., Yaney, G. C., & BOYD, A. E. (1993) · Endocrinology · doi:10.1210/endo.132.5.8386610 · Cited by 19
Involvement of vasopressin V1b receptor in anti-anxiety action of SSRI and SNRI in mice
Ishizuka, Y., Abe, H., Tanoue, A., Kannan, H., & Ishida, Y. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.11.004 · Cited by 19
Self-citationJoubert, M., Louiset, E., do Rego, J. L., Contesse, V., Kong, L. C., Benhaïm, A., Mittre, H., Lefèbvre, H., Reznik, Y., & for the REHOS Study Group (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03106.x · Cited by 19
Localisation of oxytocin, vasopressin and parts of precursors in the human neonatal adrenal
Ravid, R., Oosterbaan, H. P., Hansen, B. L., & Swaab, D. F. (1986) · Histochemistry and Cell Biology · doi:10.1007/bf00482970 · Cited by 19
Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.
Chini, B., Mouillac, B., Ala, Y., Balestre, M., de la Cotte, N., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., & Manning, M. (1995) · PubMed · Cited by 18
Boer, G. J., van Heerikhuize, J. J., & van der Woude, T. P. (1988) · European Journal of Endocrinology · doi:10.1530/acta.0.1170442 · Cited by 17
MITCHELL, C., & Goldman, M. B. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.04.002 · Cited by 17
Laycock, J. F. (2009) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781848162952 · Cited by 17
Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction
Izumi, Y., Nakayama, Y., Memetimin, H., Inoue, T., Kohda, Y., Nonoguchi, H., & Tomita, K. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00119.2008 · Cited by 16
Self-citationPharmacological prevention of prematurity
Groom, K. M. (2007) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2007.03.010 · Cited by 16
Richardson, S. B., Laya, T., & VanOoy, M. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1470059 · Cited by 15
MacKinnon, A. C., Tufail-Hanif, U., Wheatley, M., Rossi, A. G., Haslett, C., Seckl, M. J., & Sethi, T. (2008) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00003.x · Cited by 15
Meynen, G., Unmehopa, U. A., Hofman, M. A., Swaab, D. F., & Hoogendijk, W. J. G. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01890.x · Cited by 15
The origin of the glucose in the hyperglycæmia induced by pituitrin
Clark, G. A. (1928) · The Journal of Physiology · doi:10.1113/jphysiol.1928.sp002442 · Cited by 15
Tanoue, A. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r15fm · Cited by 15
Self-citationLack of vasopressin receptors in liver, but not in kidney, of ob/ob mice
Assimacopoulos‐Jeannet, F., Cantau, B., van de Werve, G., Jard, S., & Jeanrenaud, B. (1983) · Biochemical Journal · doi:10.1042/bj2160475 · Cited by 14
Brudieux, R., Krifi, M. N., & Laulin, J. (1986) · Journal of Endocrinology · doi:10.1677/joe.0.1110375 · Cited by 14
Lin, C., Lin, S., Shyu, M., Chen, S., & Lee, C. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60097-8 · Cited by 14
Role of Urinary Arginine Vasopressin in the Sodium Excretion in Patients With Chronic Renal Failure
Nonoguchi, H., Takayama, M., Owada, A., Ujiie, K., Yamada, T., Nakashima, O., Sakuma, Y., Koike, J., Terada, Y., Marumo, F., et al. (1996) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)41815-4 · Cited by 14
Self-citationLevy, A., Lightman, S. L., HOYLAND, J., & Mason, W. T. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00467.x · Cited by 13
Kumamoto, K., Matsuura, T., Amagai, T., & Kawata, M. (1995) · Cell and Tissue Research · doi:10.1007/bf00307953 · Cited by 13
Harland, D., Gardiner, S. M., & Bennett, T. M. (1989) · Circulation Research · doi:10.1161/01.res.65.4.925 · Cited by 13
Price, S., Trenfield, S., Jagger, S., Jordan, S., & Evans, T. (2005) · Critical Care · doi:10.1186/cc3275 · Cited by 10
Vasopressin in Liver Disease – Should We Turn On or Off?
Lo, R., Austin, A. S., & Freeman, J. G. (2008) · Current Clinical Pharmacology · doi:10.2174/157488408785747728 · Cited by 10
Scheuer, D. A., & Bishop, V. S. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.6.h1963 · Cited by 10
San Antonio Vasopressin in Shock Symposium Report
Cohn, S. M., Blackbourne, L. H., Landry, D. W., Proctor, K. G., Walley, K. R., & Wenzel, V. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.06.005 · Cited by 9
Memetimin, H., Izumi, Y., Nakayama, Y., Kohda, Y., Inoue, H., Nonoguchi, H., & Tomita, K. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90520.2008 · Cited by 9
Self-citationCardiovascular depression and stabilization by central vasopressin in rats.
Imai, Y., Abe, K., Sasaki, S., Minami, N., Munakata, M., Sakuma, H., Hashimoto, J., Nobunaga, T., Sekino, H., & Yoshinaga, K. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.291 · Cited by 9
V1b Receptors: New Probes for Therapy
Arban, R. (2007) · Endocrinology · doi:10.1210/en.2007-0735 · Cited by 8
Age-dependent role of vasopressin in susceptibility of gastric mucosa to indomethacin-induced injury
Zelena, D., & Filaretova, L. P. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2009.12.015 · Cited by 8
Léone, M. (2009) · Critical Care · doi:10.1186/cc8035 · Cited by 7
Metcalfe, A. M. J., Phillips, P., Dixon, R. M., & Radda, G. K. (1997) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0180161 · Cited by 5
Suzuki, S., Uchida, D., Koide, H., Suyama, K., Shibata, T., Yoshida, T., Tanaka, T., Noguchi, Y., Saitō, Y., & Tatsuno, I. (2008) · Peptides · doi:10.1016/j.peptides.2008.09.001 · Cited by 5
UNDERSTANDING THE ROLE OF VASOPRESSIN IN THE HYPOTHALAMO-PITUITARY ADRENOCORTICAL AXIS
Buckingham, J. C. (2009) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781848162952_0009 · Cited by 4
EFFECT OF VASOPRESSIN ON THE RELEASE OF CATECHOLAMINE FROM THE ADRENAL GLAND OF RAT
Kanazawa, T., Itoh, S., & Arimura, A. (1963) · The Japanese Journal of Physiology · doi:10.2170/jjphysiol.13.341 · Cited by 1
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Dumais, K. M., & Veenema, A. H. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.04.003 · Cited by 520
“Upon its central release, VP can modulate the activation of many brain regions via binding to vasopressin receptors (discussed further in section 3.a.), thereby regulating social, emotional, and cognitive behaviors (Veenema & Neumann, 2008; Koshimizu et al., 2012; Albers, 2014).”
BackgroundIntranasal oxytocin treatment for social deficits and biomarkers of response in children with autism
Parker, K. J., Oztan, O., Libove, R. A., Sumiyoshi, R. D., Jackson, L. P., Karhson, D. S., Summers, J. E., Hinman, K. E., Motonaga, K. S., Phillips, J. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705521114 · Cited by 349
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Kormos, V., & Gaszner, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.014 · Cited by 329
Song, Z., & Albers, H. E. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.10.004 · Cited by 244
“Because OTRs, V1aRs, V1bRs, and V2Rs are found on peripheral tissues of virtually every major physiological system of the body, the impact of these peptides is likely to be very widespread [2; 20].”
Background
Metadata
- Authors
- Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2012-10
- Volume
- 92
- Issue
- 4
- Pages
- 1813-1864
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2129819610
- Cited by
- 407
- References
- 515
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.